Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-26-029192
Filing Date
2026-07-21
Accepted
2026-07-21 21:00:17
Documents
2
Period of Report
2026-07-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3350
2 EXHIBIT 24 ef20078355_ex24.htm EX-24 6697
  Complete submission text file 0001140361-26-029192.txt   11612
Mailing Address 7TH FLOOR, 50 BROADWAY LONDON UNITED KINGDOM United Kingdom SW1H 0DB
Business Address 7TH FLOOR, 50 BROADWAY LONDON UNITED KINGDOM United Kingdom SW1H 0DB 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 101 WEST HAMPTON ROAD PHILADELPHIA PA 19118
Business Address
Epperly Melissa B, (Reporting) CIK: 0001807359 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40782 | Film No.: 261191512